Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameOrbusneich
Stock Code06929
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities一家專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商,亦專攻冠狀動脈支架產品,並積極擴展至神經血管介入及結構性心臟病領域。
Listing Date2022-12-23
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港新界沙田香港科學園20E號樓3樓303室和305室
Business Address (Hong Kong)香港新界沙田香港科學園20E號樓3樓303室和305室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteorbusneich.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 8.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 4,400
Par ValueTo be extracted
Offer Period2022-12-13 to 2022-12-16
Global Offering Shares54,633,000 shares
HK Public Offer Shares (Initial)5,464,000 shares (10.0%)
Public Offer Lots (Initial)10,928lots (Pool A5,464lots,Pool B5,464lots)
International Placing Shares (Initial)49,169,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO827,769,937 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share65.3%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 480,770,400

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 4,400
2 lots 1,000 HK$ 8,800
3 lots 1,500 HK$ 13,200
4 lots 2,000 HK$ 17,600
5 lots 2,500 HK$ 22,000
6 lots 3,000 HK$ 26,400
7 lots 3,500 HK$ 30,800
8 lots 4,000 HK$ 35,200
9 lots 4,500 HK$ 39,600
10 lots 5,000 HK$ 44,000
12 lots 6,000 HK$ 52,800
14 lots 7,000 HK$ 61,600
16 lots 8,000 HK$ 70,400
18 lots 9,000 HK$ 79,200
20 lots 10,000 HK$ 88,000
30 lots 15,000 HK$ 132,000
40 lots 20,000 HK$ 176,000
50 lots 25,000 HK$ 220,000
60 lots 30,000 HK$ 264,000
70 lots 35,000 HK$ 308,000
80 lots 40,000 HK$ 352,000
90 lots 45,000 HK$ 396,000
100 lots 50,000 HK$ 440,000
120 lots 60,000 HK$ 528,000
140 lots 70,000 HK$ 616,000
160 lots 80,000 HK$ 704,000
180 lots 90,000 HK$ 792,000
200 lots 100,000 HK$ 880,000
400 lots 200,000 HK$ 1,760,000
500 lots 250,000 HK$ 2,200,000
800 lots 400,000 HK$ 3,520,000
1,000 lots 500,000 HK$ 4,400,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,200 lots 600,000 HK$ 5,280,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 3.17B
Est. Threshold HK$ 9.69B
Analysis Result HK market cap below threshold, need +205%

Valuation & Financials

Market Cap (at Offer Price)HK$ 7,284,375,446
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損約4.4百萬美元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 113,970,400
Listing Expenses / Funds Raised~23.71%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 USD
Income Statement
Item 201920202021
Revenue 96,34288,472116,462
Cost of sales -30,895-30,452-35,290
Gross profit 65,44758,02081,172
Other income and gains, net 1,5003,310365
Selling and distribution expenses -32,251-15,707-26,694
Administrative expenses -19,958-14,654-8,187
Operating profit 7,9898,69419,440
Net finance costs -482-1,393-5,595
Share of associates and JVs 00-46
Profit before tax 7,5077,255-1,318
Income tax expense -549-184-3,126
Profit for the year 6,9587,071-4,444
Profit attributable to owners 6,9587,071-4,444
Balance Sheet
Item 2019202020212022-06
Cash and cash equivalents 13,63115,112175,886
Trade and bills receivables 21,51529,17933,172
Inventories 976275927
Total current assets 74,17774,467235,355
Total assets 95,692103,646268,527
Total current liabilities 144,68155,46616,450
Total liabilities 247,98368,75085,415
Total equity -152,29134,896183,112
Equity attributable to owners -152,29134,896183,112
Interest-bearing borrowings 38,46239,89800
Cash Flow Statement
Item 2019202020212022-06
Net cash from operating activities 1,59012,66620,498
Net cash from investing activities -3,053-11,245-5,219
Net cash from financing activities 163,05036,000-58,384
Net increase in cash 161,58737,421-43,105
Purchase of PP&E -2,732-943-1,247-935
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 9.15
First Day OpenHK$ 8.8
First Day Change3.98%
First Day Volume4592500.0
First Day Turnover40174300.0
Use of Proceeds
1、30.0%(或約110.0百萬港元)分配予在研產品開發及商業化; 2、54.2%(或約198.8百萬港元)被分配用于擴大我們的產能; 3、10.8%(或約39.7百萬港元)用于為潛在戰略收購、建立戰略合作伙伴關系及其他業務發展提供資金; 4、5.0%(或約18.3百萬港元)用作營運資金及用于其他一般企業事項。

Underwriting Syndicate

Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 建银国际金融有限公司 CE AJO225
Overall Coordinators (5)
中国国际金融香港证券有限公司 CE AEN894 建银国际金融有限公司 CE AJO225 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 CLSA LIMITED CE AAB893 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Bookrunners (8)
中国国际金融香港证券有限公司 CE AEN894 建银国际金融有限公司 CE AJO225 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 CLSA LIMITED CE AAB893 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 ZMF Asset Management Limited CE AWF641 富途证券国际(香港)有限公司 CE AZT137 YUE XIU SECURITIES COMPANY LIMITED CE ABQ722
Joint Lead Managers (8)
中国国际金融香港证券有限公司 CE AEN894 建银国际金融有限公司 CE AJO225 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 CLSA LIMITED CE AAB893 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 ZMF Asset Management Limited CE AWF641 富途证券国际(香港)有限公司 CE AZT137 YUE XIU SECURITIES COMPANY LIMITED CE ABQ722

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 杭州富阳产业基金投资管理有限公司 313,997,200 HKD — 65.31% — 6 months 2023-06-23

Directors & Management

PositionChinese nameEnglish Name
Chairman錢永勛—
Company Secretary陳泳成—
No director data available.

Major Shareholders

Major Shareholders & HoldingsHART持有本公司63.00%已發行股本,錢永勛先生及劉桂禎女士分別持有HART 55%及45%股權;深圳市創新投資集團有限公司持有11.84%。
About this page

This page shows Orbusneich (06929) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect